In silico design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cells

Mourad Aloui(Sidi Mohamed Ben Abdellah University), Elhalaoui Menana(Sidi Mohamed Ben Abdellah University), Hatem A. Abuelizz(King Saud University), Sara Er-Rahmani(University of Turin), Mohamed El fadili(Sidi Mohamed Ben Abdellah University), Somdutt Mujwar(Chitkara University), Mohammed Er-rajy(Euro-Mediterranean University of Fes)
Frontiers in Chemistry
July 28, 2025
10.3389/fchem.2025.1590593
Cited by 1

Related Papers

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia
|Pharmaceuticals|2022|71
Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation
|Journal of Biomolecular Structure and Dynamics|2023|55
2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives
|Structural Chemistry|2022|54
3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists
|Processes|2022|53
QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties
|Heliyon|2023|46